XKR8 and neoplasm: Subsequently, using CRISPR/Cas9 gene editing to individually knockout Xkr8 or TMEM16F, we show that both PS scramblases directly contribute to immune regulation and tumor growth in immune-competent mice but not in NOD/SCID or Rag1 KO immune-deficient mice.